Last 12 months
Inside the activity.
0 purchase rows · 16 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 2 |
| Dec 2025 | 0 | 2 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 1 |
| Mar 2026 | 0 | 2 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 4 |
| Jun 2026 | 0 | 5 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 15, 2018 Filed Feb 15, 2018 23:31 UTC |
Noot WalterChief Information Officer
|
SaleCommon Stock | 3,075 | $77.00 | $236,775.00 |
DisclosureSEC source: 0001179110-18-002202 · edgar.xml · nonDerivative · entry 2 Noot Walter · CIK 0001691991 · Chief Information Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Read SEC document |
| February 15, 2018 Filed Feb 15, 2018 23:31 UTC |
Noot WalterChief Information Officer
|
Exercise / conversionCommon Stock | 3,075 | $62.20 | $191,265.00 |
DisclosureSEC source: 0001179110-18-002202 · edgar.xml · nonDerivative · entry 1 Noot Walter · CIK 0001691991 · Chief Information Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,075 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The shares acquired resulted from the reporting person's settlement of the stock-settled stock appreciation rights disclosed in Table II. Read SEC document |
| February 15, 2018 Filed Feb 16, 2018 22:59 UTC |
Gull Global Ltd10% owner
|
SaleCommon Stock | 19,167 | $76.57 | $1,467,546.27 |
DisclosureSEC source: 0001179110-18-002304 · edgar.xml · nonDerivative · entry 2 Gull Global Ltd · CIK 0001636301 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,562,053 F1 · shares: The holder of record of the shares of Common Stock disposed is Gull Global Limited, an entity wholly indirectly owned and controlled by Dr. Myron W. Wentz. F3 · price: Weighted average price. Price range in multiple transactions was $75.65 to $77.25, inclusive. The reporting person undertakes to provide USANA Health Sciences, Inc., any security holder thereof or the staff at the Securities and Exchange Commission information regarding the number of shares sold at each price within the ranges set forth. Read SEC document |
| February 15, 2018 Filed Feb 16, 2018 22:58 UTC |
WENTZ MYRON WDirector
|
SaleCommon Stock | 19,167 | $76.57 | $1,467,546.27 |
DisclosureSEC source: 0001179110-18-002303 · edgar.xml · nonDerivative · entry 2 WENTZ MYRON W · CIK 0001203301 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Shares owned of record by Gull Global Limited Disclosed balance after: 11,562,053 F1 · shares: The holder of record of the shares of Common Stock disposed is Gull Global Limited, an entity wholly indirectly owned and controlled by Dr. Myron W. Wentz. F3 · price: Weighted average price. Price range in multiple transactions was $75.65 to $77.25, inclusive. The reporting person undertakes to provide USANA Health Sciences, Inc., any security holder thereof or the staff at the Securities and Exchange Commission information regarding the number of shares sold at each price within the ranges set forth. Read SEC document |
| February 14, 2018 Filed Feb 16, 2018 22:59 UTC |
Gull Global Ltd10% owner
|
SaleCommon Stock | 34,205 | $75.70 | $2,589,198.78 |
DisclosureSEC source: 0001179110-18-002304 · edgar.xml · nonDerivative · entry 1 Gull Global Ltd · CIK 0001636301 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,581,220 F1 · shares: The holder of record of the shares of Common Stock disposed is Gull Global Limited, an entity wholly indirectly owned and controlled by Dr. Myron W. Wentz. F2 · price: Weighted average price. Price range in multiple transactions was $74.75 to $75.90, inclusive. The reporting person undertakes to provide USANA Health Sciences, Inc., any security holder thereof or the staff at the Securities and Exchange Commission information regarding the number of shares sold at each price within the ranges set forth. Read SEC document |
| February 14, 2018 Filed Feb 16, 2018 22:58 UTC |
WENTZ MYRON WDirector
|
SaleCommon Stock | 34,205 | $75.70 | $2,589,198.78 |
DisclosureSEC source: 0001179110-18-002303 · edgar.xml · nonDerivative · entry 1 WENTZ MYRON W · CIK 0001203301 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Shares owned of record by Gull Global Limited Disclosed balance after: 11,581,220 F1 · shares: The holder of record of the shares of Common Stock disposed is Gull Global Limited, an entity wholly indirectly owned and controlled by Dr. Myron W. Wentz. F2 · price: Weighted average price. Price range in multiple transactions was $74.75 to $75.90, inclusive. The reporting person undertakes to provide USANA Health Sciences, Inc., any security holder thereof or the staff at the Securities and Exchange Commission information regarding the number of shares sold at each price within the ranges set forth. Read SEC document |
| February 13, 2018 Filed Feb 13, 2018 23:57 UTC |
Gull Global Ltd10% owner
|
SaleCommon Stock | 16,134 | $75.46 | $1,217,518.43 |
DisclosureSEC source: 0001179110-18-002034 · edgar.xml · nonDerivative · entry 3 Gull Global Ltd · CIK 0001636301 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,615,425 F1 · shares: The holder of record of the shares of Common Stock disposed is Gull Global Limited, an entity wholly indirectly owned and controlled by Dr. Myron W. Wentz. F4 · price: Weighted average price. Price range in multiple transactions was $74.95 to $75.60, inclusive. The reporting person undertakes to provide USANA Health Sciences, Inc., any security holder thereof or the staff at the Securities and Exchange Commission information regarding the number of shares sold at each price within the ranges set forth. Read SEC document |
| February 13, 2018 Filed Feb 13, 2018 23:57 UTC |
WENTZ MYRON WDirector
|
SaleCommon Stock | 16,134 | $75.46 | $1,217,518.43 |
DisclosureSEC source: 0001179110-18-002033 · edgar.xml · nonDerivative · entry 3 WENTZ MYRON W · CIK 0001203301 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Shares owned of record by Gull Global Limited Disclosed balance after: 11,615,425 F1 · shares: The holder of record of the shares of Common Stock disposed is Gull Global Limited, an entity wholly indirectly owned and controlled by Dr. Myron W. Wentz. F4 · price: Weighted average price. Price range in multiple transactions was $74.95 to $75.60, inclusive. The reporting person undertakes to provide USANA Health Sciences, Inc., any security holder thereof or the staff at the Securities and Exchange Commission information regarding the number of shares sold at each price within the ranges set forth. Read SEC document |
| February 12, 2018 Filed Feb 13, 2018 23:57 UTC |
Gull Global Ltd10% owner
|
SaleCommon Stock | 10,287 | $75.39 | $775,530.76 |
DisclosureSEC source: 0001179110-18-002034 · edgar.xml · nonDerivative · entry 2 Gull Global Ltd · CIK 0001636301 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,631,559 F1 · shares: The holder of record of the shares of Common Stock disposed is Gull Global Limited, an entity wholly indirectly owned and controlled by Dr. Myron W. Wentz. F3 · price: Weighted average price. Price range in multiple transactions was $74.70 to $76.10, inclusive. The reporting person undertakes to provide USANA Health Sciences, Inc., any security holder thereof or the staff at the Securities and Exchange Commission information regarding the number of shares sold at each price within the ranges set forth. Read SEC document |
| February 12, 2018 Filed Feb 13, 2018 23:57 UTC |
WENTZ MYRON WDirector
|
SaleCommon Stock | 10,287 | $75.39 | $775,530.76 |
DisclosureSEC source: 0001179110-18-002033 · edgar.xml · nonDerivative · entry 2 WENTZ MYRON W · CIK 0001203301 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Shares owned of record by Gull Global Limited Disclosed balance after: 11,631,559 F1 · shares: The holder of record of the shares of Common Stock disposed is Gull Global Limited, an entity wholly indirectly owned and controlled by Dr. Myron W. Wentz. F3 · price: Weighted average price. Price range in multiple transactions was $74.70 to $76.10, inclusive. The reporting person undertakes to provide USANA Health Sciences, Inc., any security holder thereof or the staff at the Securities and Exchange Commission information regarding the number of shares sold at each price within the ranges set forth. Read SEC document |
| February 09, 2018 Filed Feb 13, 2018 23:57 UTC |
Gull Global Ltd10% owner
|
SaleCommon Stock | 1,984 | $74.78 | $148,358.76 |
DisclosureSEC source: 0001179110-18-002034 · edgar.xml · nonDerivative · entry 1 Gull Global Ltd · CIK 0001636301 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,641,846 F1 · shares: The holder of record of the shares of Common Stock disposed is Gull Global Limited, an entity wholly indirectly owned and controlled by Dr. Myron W. Wentz. F2 · price: Weighted average price. Price range in multiple transactions was $73.50 to $75.55, inclusive. The reporting person undertakes to provide USANA Health Sciences, Inc., any security holder thereof or the staff at the Securities and Exchange Commission information regarding the number of shares sold at each price within the ranges set forth. Read SEC document |
| February 09, 2018 Filed Feb 13, 2018 23:57 UTC |
WENTZ MYRON WDirector
|
SaleCommon Stock | 1,984 | $74.78 | $148,358.76 |
DisclosureSEC source: 0001179110-18-002033 · edgar.xml · nonDerivative · entry 1 WENTZ MYRON W · CIK 0001203301 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Shares owned of record by Gull Global Limited Disclosed balance after: 11,641,846 F1 · shares: The holder of record of the shares of Common Stock disposed is Gull Global Limited, an entity wholly indirectly owned and controlled by Dr. Myron W. Wentz. F2 · price: Weighted average price. Price range in multiple transactions was $73.50 to $75.55, inclusive. The reporting person undertakes to provide USANA Health Sciences, Inc., any security holder thereof or the staff at the Securities and Exchange Commission information regarding the number of shares sold at each price within the ranges set forth. Read SEC document |
| February 06, 2018 Filed Feb 7, 2018 00:37 UTC |
Gull Global Ltd10% owner
|
SaleCommon Stock | 27,126 | $71.00 | $1,925,940.57 |
DisclosureSEC source: 0001179110-18-001680 · edgar.xml · nonDerivative · entry 4 Gull Global Ltd · CIK 0001636301 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,643,830 F1 · shares: The holder of record of the shares of Common Stock disposed is Gull Global Limited, an entity wholly indirectly owned and controlled by Dr. Myron W. Wentz. F4 · price: Weighted average price. Price range in multiple transactions was $69.55 to $71.55, inclusive. The reporting person undertakes to provide USANA Health Sciences, Inc., any security holder thereof or the staff at the Securities and Exchange Commission information regarding the number of shares sold at each price within the ranges set forth. Read SEC document |
| February 06, 2018 Filed Feb 7, 2018 00:37 UTC |
WENTZ MYRON WDirector
|
SaleCommon Stock | 27,126 | $71.00 | $1,925,940.57 |
DisclosureSEC source: 0001179110-18-001679 · edgar.xml · nonDerivative · entry 4 WENTZ MYRON W · CIK 0001203301 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Shares owned of record by Gull Global Limited Disclosed balance after: 11,643,830 F1 · shares: The holder of record of the shares of Common Stock disposed is Gull Global Limited, an entity wholly indirectly owned and controlled by Dr. Myron W. Wentz. F4 · price: Weighted average price. Price range in multiple transactions was $69.55 to $71.55, inclusive. The reporting person undertakes to provide USANA Health Sciences, Inc., any security holder thereof or the staff at the Securities and Exchange Commission information regarding the number of shares sold at each price within the ranges set forth. Read SEC document |
| February 06, 2018 Filed Feb 7, 2018 22:38 UTC |
Mulham David MulhamChief Field Development Office
|
Exercise / conversionRestricted Stock Units · Derivative | 873 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-18-001743 · edgar.xml · derivative · entry 3 Mulham David Mulham · CIK 0001697433 · Chief Field Development Office 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,769 Underlying: Common Stock · 873 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of USNA common stock. F3 · derivative.exercise_date: On May 1st, 2017, the reporting person was granted 3,492 restricted stock units, vesting at 25% on each 6th of February thereafter. F3 · derivative.expiration_date: On May 1st, 2017, the reporting person was granted 3,492 restricted stock units, vesting at 25% on each 6th of February thereafter. Read SEC document |
| February 06, 2018 Filed Feb 7, 2018 22:38 UTC |
Mulham David MulhamChief Field Development Office
|
Exercise / conversionCommon Stock | 873 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001179110-18-001743 · edgar.xml · nonDerivative · entry 1 Mulham David Mulham · CIK 0001697433 · Chief Field Development Office 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 873 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of USNA common stock. Read SEC document |
| February 06, 2018 Filed Feb 7, 2018 22:37 UTC |
Macuga Daniel A.Chief Communications Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 873 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-18-001742 · edgar.xml · derivative · entry 4 Macuga Daniel A. · CIK 0001537768 · Chief Communications Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,769 Underlying: Common Stock · 873 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of USNA common stock. F3 · derivative.exercise_date: On May 1st, 2017, the reporting person was granted 3,492 restricted stock units, vesting at 25% on each 6th of February thereafter. F3 · derivative.expiration_date: On May 1st, 2017, the reporting person was granted 3,492 restricted stock units, vesting at 25% on each 6th of February thereafter. Read SEC document |
| February 06, 2018 Filed Feb 7, 2018 22:37 UTC |
Macuga Daniel A.Chief Communications Officer
|
Tax withholdingCommon Stock | 370 | $70.75 | $26,177.50 |
DisclosureSEC source: 0001179110-18-001742 · edgar.xml · nonDerivative · entry 2 Macuga Daniel A. · CIK 0001537768 · Chief Communications Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 503 Read SEC document |
| February 06, 2018 Filed Feb 7, 2018 22:37 UTC |
Macuga Daniel A.Chief Communications Officer
|
Exercise / conversionCommon Stock | 873 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001179110-18-001742 · edgar.xml · nonDerivative · entry 1 Macuga Daniel A. · CIK 0001537768 · Chief Communications Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 873 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of USNA common stock. Read SEC document |
| February 06, 2018 Filed Feb 7, 2018 22:36 UTC |
Guest KevinC.E.O.
|
Exercise / conversionRestricted Stock Units · Derivative | 1,373 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-18-001740 · edgar.xml · derivative · entry 4 Guest Kevin · CIK 0001353496 · C.E.O. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,013 Underlying: Common Stock · 1,373 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of USNA common stock F3 · derivative.exercise_date: On May 1st, 2017, the reporting person was granted 5,493 restricted stock units, vesting at 25% on each 6th of February thereafter. F3 · derivative.expiration_date: On May 1st, 2017, the reporting person was granted 5,493 restricted stock units, vesting at 25% on each 6th of February thereafter. Read SEC document |
| February 06, 2018 Filed Feb 7, 2018 22:36 UTC |
Guest KevinC.E.O.
|
Tax withholdingCommon Stock | 582 | $70.75 | $41,176.50 |
DisclosureSEC source: 0001179110-18-001740 · edgar.xml · nonDerivative · entry 2 Guest Kevin · CIK 0001353496 · C.E.O. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 791 Read SEC document |
| February 06, 2018 Filed Feb 7, 2018 22:36 UTC |
Guest KevinC.E.O.
|
Exercise / conversionCommon Stock | 1,373 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001179110-18-001740 · edgar.xml · nonDerivative · entry 1 Guest Kevin · CIK 0001353496 · C.E.O. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,373 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of USNA common stock Read SEC document |
| February 06, 2018 Filed Feb 7, 2018 22:35 UTC |
Brown JimPresident & COO
|
Exercise / conversionRestricted Stock Units · Derivative | 1,373 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-18-001739 · edgar.xml · derivative · entry 4 Brown Jim · CIK 0001555707 · President & COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,562 Underlying: Common Stock · 1,373 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of USNA common stock. F3 · derivative.exercise_date: On May 1st, 2017, the reporting person was granted 5,493 restricted stock units, vesting at 25% on each 6th of February thereafter. F3 · derivative.expiration_date: On May 1st, 2017, the reporting person was granted 5,493 restricted stock units, vesting at 25% on each 6th of February thereafter. Read SEC document |
| February 06, 2018 Filed Feb 7, 2018 22:35 UTC |
Brown JimPresident & COO
|
Tax withholdingCommon Stock | 582 | $70.75 | $41,176.50 |
DisclosureSEC source: 0001179110-18-001739 · edgar.xml · nonDerivative · entry 2 Brown Jim · CIK 0001555707 · President & COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 791 Read SEC document |
| February 06, 2018 Filed Feb 7, 2018 22:35 UTC |
Brown JimPresident & COO
|
Exercise / conversionCommon Stock | 1,373 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001179110-18-001739 · edgar.xml · nonDerivative · entry 1 Brown Jim · CIK 0001555707 · President & COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,373 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of USNA common stock. Read SEC document |
| February 05, 2018 Filed Feb 7, 2018 00:37 UTC |
Gull Global Ltd10% owner
|
SaleCommon Stock | 8,344 | $72.28 | $603,123.51 |
DisclosureSEC source: 0001179110-18-001680 · edgar.xml · nonDerivative · entry 3 Gull Global Ltd · CIK 0001636301 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,670,956 F1 · shares: The holder of record of the shares of Common Stock disposed is Gull Global Limited, an entity wholly indirectly owned and controlled by Dr. Myron W. Wentz. F3 · price: Weighted average price. Price range in multiple transactions was $71.075 to $73.50, inclusive. The reporting person undertakes to provide USANA Health Sciences, Inc., any security holder thereof or the staff at the Securities and Exchange Commission information regarding the number of shares sold at each price within the ranges set forth. Read SEC document |
| February 05, 2018 Filed Feb 7, 2018 00:37 UTC |
WENTZ MYRON WDirector
|
SaleCommon Stock | 8,344 | $72.28 | $603,123.51 |
DisclosureSEC source: 0001179110-18-001679 · edgar.xml · nonDerivative · entry 3 WENTZ MYRON W · CIK 0001203301 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Shares owned of record by Gull Global Limited Disclosed balance after: 11,670,956 F1 · shares: The holder of record of the shares of Common Stock disposed is Gull Global Limited, an entity wholly indirectly owned and controlled by Dr. Myron W. Wentz. F3 · price: Weighted average price. Price range in multiple transactions was $71.075 to $73.50, inclusive. The reporting person undertakes to provide USANA Health Sciences, Inc., any security holder thereof or the staff at the Securities and Exchange Commission information regarding the number of shares sold at each price within the ranges set forth. Read SEC document |
| February 05, 2018 Filed Feb 7, 2018 22:39 UTC |
Jones Paul A.Chief Leadership Devlop Office
|
GrantRestricted Stock Units · Derivative | 4,859 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-18-001746 · edgar.xml · derivative · entry 1 Jones Paul A. · CIK 0001565541 · Chief Leadership Devlop Office 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,057 Underlying: Common Stock · 4,859 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of USNA common stock. F2 · derivative.exercise_date: Restricted Stock Units vest 25% on the anniversary of February 5th, 2018. F2 · derivative.expiration_date: Restricted Stock Units vest 25% on the anniversary of February 5th, 2018. Read SEC document |
| February 05, 2018 Filed Feb 7, 2018 22:39 UTC |
SINNOTT ROBERT AChief Scientific Officer
|
GrantRestricted Stock Units · Derivative | 5,153 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-18-001745 · edgar.xml · derivative · entry 1 SINNOTT ROBERT A · CIK 0001298819 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,462 Underlying: Common Stock · 5,153 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of USNA common stock. F2 · derivative.exercise_date: Restricted Stock Units vest 25% on the anniversary of February 5th, 2018. F2 · derivative.expiration_date: Restricted Stock Units vest 25% on the anniversary of February 5th, 2018. Read SEC document |
| February 05, 2018 Filed Feb 7, 2018 22:38 UTC |
Noot WalterChief Information Officer
|
GrantRestricted Stock Units · Derivative | 5,634 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-18-001744 · edgar.xml · derivative · entry 1 Noot Walter · CIK 0001691991 · Chief Information Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,159 Underlying: Common Stock · 5,634 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of USNA common stock. F2 · derivative.exercise_date: Restricted Stock Units vest 25% on the anniversary of February 5th, 2018. F2 · derivative.expiration_date: Restricted Stock Units vest 25% on the anniversary of February 5th, 2018. Read SEC document |
| February 05, 2018 Filed Feb 7, 2018 22:38 UTC |
Mulham David MulhamChief Field Development Office
|
GrantRestricted Stock Units · Derivative | 5,595 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-18-001743 · edgar.xml · derivative · entry 2 Mulham David Mulham · CIK 0001697433 · Chief Field Development Office 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,642 Underlying: Common Stock · 5,595 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of USNA common stock. F2 · derivative.exercise_date: Restricted Stock Units vest 25% on the anniversary of February 5th, 2018. F2 · derivative.expiration_date: Restricted Stock Units vest 25% on the anniversary of February 5th, 2018. Read SEC document |
| February 05, 2018 Filed Feb 7, 2018 22:37 UTC |
Macuga Daniel A.Chief Communications Officer
|
GrantRestricted Stock Units · Derivative | 5,595 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-18-001742 · edgar.xml · derivative · entry 3 Macuga Daniel A. · CIK 0001537768 · Chief Communications Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,642 Underlying: Common Stock · 5,595 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of USNA common stock. F2 · derivative.exercise_date: Restricted Stock Units vest 25% on the anniversary of February 5th, 2018. F2 · derivative.expiration_date: Restricted Stock Units vest 25% on the anniversary of February 5th, 2018. Read SEC document |
| February 05, 2018 Filed Feb 7, 2018 22:37 UTC | GrantRestricted Stock Units · Derivative | 5,892 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-18-001741 · edgar.xml · derivative · entry 1 IIEKKING G DOUG · CIK 0001203346 · CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,128 Underlying: Common Stock · 5,892 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of USNA common stock. F2 · derivative.exercise_date: Restricted Stock Units vest 25% on the anniversary of February 5th, 2018. F2 · derivative.expiration_date: Restricted Stock Units vest 25% on the anniversary of February 5th, 2018. Read SEC document |
|
| February 05, 2018 Filed Feb 7, 2018 22:36 UTC |
Guest KevinC.E.O.
|
GrantRestricted Stock Units · Derivative | 18,555 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-18-001740 · edgar.xml · derivative · entry 3 Guest Kevin · CIK 0001353496 · C.E.O. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,386 Underlying: Common Stock · 18,555 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of USNA common stock F2 · derivative.exercise_date: Restricted Stock Units vest 25% on the anniversary of February 5th, 2018. F2 · derivative.expiration_date: Restricted Stock Units vest 25% on the anniversary of February 5th, 2018. Read SEC document |
| February 05, 2018 Filed Feb 7, 2018 22:35 UTC |
Brown JimPresident & COO
|
GrantRestricted Stock Units · Derivative | 9,422 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-18-001739 · edgar.xml · derivative · entry 3 Brown Jim · CIK 0001555707 · President & COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,935 Underlying: Common Stock · 9,422 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of USNA common stock. F2 · derivative.exercise_date: Restricted Stock Units vest 25% on the anniversary of February 5th, 2018. F2 · derivative.expiration_date: Restricted Stock Units vest 25% on the anniversary of February 5th, 2018. Read SEC document |
| February 05, 2018 Filed Feb 7, 2018 22:34 UTC |
Bramble JamesChief Legal Officer and Sec
|
GrantRestricted Stock Units · Derivative | 5,580 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-18-001737 · edgar.xml · derivative · entry 1 Bramble James · CIK 0001441438 · Chief Legal Officer and Sec 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,129 Underlying: Common Stock · 5,580 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of USNA common stock. F2 · derivative.exercise_date: Restricted Stock Units vest 25% on the anniversary of February 5th, 2018. F2 · derivative.expiration_date: Restricted Stock Units vest 25% on the anniversary of February 5th, 2018. Read SEC document |
| February 02, 2018 Filed Feb 7, 2018 00:37 UTC |
Gull Global Ltd10% owner
|
SaleCommon Stock | 2,753 | $74.24 | $204,389.88 |
DisclosureSEC source: 0001179110-18-001680 · edgar.xml · nonDerivative · entry 2 Gull Global Ltd · CIK 0001636301 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,679,300 F1 · shares: The holder of record of the shares of Common Stock disposed is Gull Global Limited, an entity wholly indirectly owned and controlled by Dr. Myron W. Wentz. F2 · price: Weighted average price. Price range in multiple transactions was $73.60 to $74.78, inclusive. The reporting person undertakes to provide USANA Health Sciences, Inc., any security holder thereof or the staff at the Securities and Exchange Commission information regarding the number of shares sold at each price within the ranges set forth. Read SEC document |
| February 02, 2018 Filed Feb 7, 2018 00:37 UTC |
WENTZ MYRON WDirector
|
SaleCommon Stock | 2,753 | $74.24 | $204,389.88 |
DisclosureSEC source: 0001179110-18-001679 · edgar.xml · nonDerivative · entry 2 WENTZ MYRON W · CIK 0001203301 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Shares owned of record by Gull Global Limited Disclosed balance after: 11,679,300 F1 · shares: The holder of record of the shares of Common Stock disposed is Gull Global Limited, an entity wholly indirectly owned and controlled by Dr. Myron W. Wentz. F2 · price: Weighted average price. Price range in multiple transactions was $73.60 to $74.78, inclusive. The reporting person undertakes to provide USANA Health Sciences, Inc., any security holder thereof or the staff at the Securities and Exchange Commission information regarding the number of shares sold at each price within the ranges set forth. Read SEC document |
| December 29, 2017 Filed Feb 7, 2018 00:37 UTC |
Gull Global Ltd10% owner
|
GiftCommon Stock | 12,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-18-001680 · edgar.xml · nonDerivative · entry 1 Gull Global Ltd · CIK 0001636301 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,682,053 F1 · shares: The holder of record of the shares of Common Stock disposed is Gull Global Limited, an entity wholly indirectly owned and controlled by Dr. Myron W. Wentz. Read SEC document |
| December 29, 2017 Filed Feb 7, 2018 00:37 UTC |
WENTZ MYRON WDirector
|
GiftCommon Stock | 12,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-18-001679 · edgar.xml · nonDerivative · entry 1 WENTZ MYRON W · CIK 0001203301 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Shares owned of record by Gull Global Limited Disclosed balance after: 11,682,053 F1 · shares: The holder of record of the shares of Common Stock disposed is Gull Global Limited, an entity wholly indirectly owned and controlled by Dr. Myron W. Wentz. Read SEC document |
| December 11, 2017 Filed Jun 1, 2018 01:49 UTC |
Gull Global Ltd10% owner
|
PurchaseCommon Stock | 10,396 | $70.70 | $734,997.20 |
DisclosureSEC source: 0001144204-18-032135 · tv495643_4.xml · nonDerivative · entry 9 Gull Global Ltd · CIK 0001636301 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,921,609 Read SEC document |
| December 11, 2017 Filed Jun 6, 2018 01:15 UTC |
WENTZ MYRON WDirector
|
PurchaseCommon Stock | 10,396 | $70.70 | $734,997.20 |
DisclosureSEC source: 0001144204-18-032921 · tv495958_4.xml · nonDerivative · entry 9 WENTZ MYRON W · CIK 0001203301 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Shares owned of record by Gull Global Limited Disclosed balance after: 10,921,609 F12 · ownership.nature: The holder of record of the shares of Common Stock disposed or purchased is Gull Global Limited, an entity wholly indirectly owned and controlled by Dr. Myron W. Wentz. The reported transactions were previously reported on a Form 4 filed on May 31, 2018 by Gull Global Limited. Read SEC document |
| December 08, 2017 Filed Jun 1, 2018 01:49 UTC |
Gull Global Ltd10% owner
|
PurchaseCommon Stock | 824 | $70.70 | $58,256.80 |
DisclosureSEC source: 0001144204-18-032135 · tv495643_4.xml · nonDerivative · entry 8 Gull Global Ltd · CIK 0001636301 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,911,213 Read SEC document |
| December 08, 2017 Filed Jun 6, 2018 01:15 UTC |
WENTZ MYRON WDirector
|
PurchaseCommon Stock | 824 | $70.70 | $58,256.80 |
DisclosureSEC source: 0001144204-18-032921 · tv495958_4.xml · nonDerivative · entry 8 WENTZ MYRON W · CIK 0001203301 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Shares owned of record by Gull Global Limited Disclosed balance after: 10,911,213 F12 · ownership.nature: The holder of record of the shares of Common Stock disposed or purchased is Gull Global Limited, an entity wholly indirectly owned and controlled by Dr. Myron W. Wentz. The reported transactions were previously reported on a Form 4 filed on May 31, 2018 by Gull Global Limited. Read SEC document |
| December 07, 2017 Filed Jun 1, 2018 01:49 UTC |
Gull Global Ltd10% owner
|
PurchaseCommon Stock | 6,697 | $70.46 | $471,870.62 |
DisclosureSEC source: 0001144204-18-032135 · tv495643_4.xml · nonDerivative · entry 7 Gull Global Ltd · CIK 0001636301 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,910,389 F2 · price: The reporting person undertakes to provide USANA Health Sciences, Inc., any security holder thereof or the staff at the Securities and Exchange Commission information regarding the number of shares sold at each price within the ranges set forth. F6 · price: Weighted average price. Price range in multiple transactions was $70.15 to $70.70, inclusive. Read SEC document |
| December 07, 2017 Filed Jun 6, 2018 01:15 UTC |
WENTZ MYRON WDirector
|
PurchaseCommon Stock | 6,697 | $70.46 | $471,870.62 |
DisclosureSEC source: 0001144204-18-032921 · tv495958_4.xml · nonDerivative · entry 7 WENTZ MYRON W · CIK 0001203301 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Shares owned of record by Gull Global Limited Disclosed balance after: 10,910,389 F2 · price: The reporting person undertakes to provide USANA Health Sciences, Inc., any security holder thereof or the staff of the Securities and Exchange Commission information regarding the number of shares sold at each price within the ranges set forth. F6 · price: Weighted average price. Price range in multiple transactions was $70.15 to $70.70, inclusive. F12 · ownership.nature: The holder of record of the shares of Common Stock disposed or purchased is Gull Global Limited, an entity wholly indirectly owned and controlled by Dr. Myron W. Wentz. The reported transactions were previously reported on a Form 4 filed on May 31, 2018 by Gull Global Limited. Read SEC document |
| December 06, 2017 Filed Jun 1, 2018 01:49 UTC |
Gull Global Ltd10% owner
|
PurchaseCommon Stock | 1,200 | $70.70 | $84,840.00 |
DisclosureSEC source: 0001144204-18-032135 · tv495643_4.xml · nonDerivative · entry 6 Gull Global Ltd · CIK 0001636301 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,903,692 Read SEC document |
| December 06, 2017 Filed Jun 6, 2018 01:15 UTC |
WENTZ MYRON WDirector
|
PurchaseCommon Stock | 1,200 | $70.70 | $84,840.00 |
DisclosureSEC source: 0001144204-18-032921 · tv495958_4.xml · nonDerivative · entry 6 WENTZ MYRON W · CIK 0001203301 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Shares owned of record by Gull Global Limited Disclosed balance after: 10,903,692 F12 · ownership.nature: The holder of record of the shares of Common Stock disposed or purchased is Gull Global Limited, an entity wholly indirectly owned and controlled by Dr. Myron W. Wentz. The reported transactions were previously reported on a Form 4 filed on May 31, 2018 by Gull Global Limited. Read SEC document |
| December 04, 2017 Filed Jun 1, 2018 01:49 UTC |
Gull Global Ltd10% owner
|
SaleCommon Stock | 500 | $70.79 | $35,395.00 |
DisclosureSEC source: 0001144204-18-032135 · tv495643_4.xml · nonDerivative · entry 5 Gull Global Ltd · CIK 0001636301 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,902,492 F2 · price: The reporting person undertakes to provide USANA Health Sciences, Inc., any security holder thereof or the staff at the Securities and Exchange Commission information regarding the number of shares sold at each price within the ranges set forth. F5 · price: Weighted average price. Price range in multiple transactions was $70.75 to $70.85, inclusive. Read SEC document |
| December 04, 2017 Filed Jun 1, 2018 01:49 UTC |
Gull Global Ltd10% owner
|
SaleCommon Stock | 6,181 | $70.44 | $435,389.64 |
DisclosureSEC source: 0001144204-18-032135 · tv495643_4.xml · nonDerivative · entry 4 Gull Global Ltd · CIK 0001636301 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,902,992 F2 · price: The reporting person undertakes to provide USANA Health Sciences, Inc., any security holder thereof or the staff at the Securities and Exchange Commission information regarding the number of shares sold at each price within the ranges set forth. F4 · price: Weighted average price. Price range in multiple transactions was $69.75 to $70.725, inclusive. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.